Related Experiment Video
Updated: Dec 28, 2025
06:39
Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
3.4K
Use of Brexanolone for Postpartum Depression.
1Dr. Scarff is with the Behavioral Health Service Line, Kenner Army Health Clinic, in Fort Lee, Virginia.
Innovations in Clinical Neuroscience
|February 22, 2020
Summary
Postpartum depression (PPD) may be treated with brexanolone (BRX), an intravenous allopregnanolone solution. BRX rapidly reduced or achieved remission of PPD symptoms in clinical studies.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Postpartum depression (PPD) is a prevalent condition impacting mothers, infants, and families.
- Current treatments like psychotherapy and pharmacotherapy have limitations, including delayed response or lack of remission.
- Altered allopregnanolone levels and GABAA receptor dysfunction may contribute to PPD pathophysiology.
Purpose of the Study:
- To evaluate the efficacy and safety of brexanolone (BRX) for treating postpartum depression.
- To investigate brexanolone's potential to rapidly alleviate PPD symptoms by modulating GABAA receptors.
Main Methods:
- Intravenous administration of brexanolone (BRX), a solution of allopregnanolone.
- Clinical studies involving patients with postpartum depression.
- Monitoring for symptom reduction, remission, and adverse events such as sedation or syncope.
Main Results:
- Patients receiving brexanolone (BRX) demonstrated a rapid reduction or remission of postpartum depression symptoms.
- Brexanolone (BRX) administration is associated with risks including sedation and syncope.
- The drug is available through a national registry requiring supervised medical administration and monitoring.
Conclusions:
- Brexanolone (BRX) offers a rapid treatment option for postpartum depression by restoring allopregnanolone levels and modulating GABAA receptors.
- Due to safety concerns, brexanolone (BRX) requires administration in a supervised medical setting.
- Further research is necessary to ascertain the long-term efficacy of brexanolone (BRX) in managing PPD.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
705
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
705
01:27Depressive Disorders: MDD and Dysthymia
480
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
480
01:25Antidepressant Drugs: Overview
1.2K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.2K
01:18Depression: Overview
678
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
678
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
2.2K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
2.2K
01:30Bipolar Disorder
536
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
536